600216 Stock Overview
Manufactures and sells life nutrition and pharmaceutical products in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Zhejiang Medicine Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥14.68 |
52 Week High | CN¥17.50 |
52 Week Low | CN¥7.97 |
Beta | -0.059 |
11 Month Change | 18.10% |
3 Month Change | 44.63% |
1 Year Change | 40.48% |
33 Year Change | -10.10% |
5 Year Change | 11.21% |
Change since IPO | 39.41% |
Recent News & Updates
Recent updates
Shareholder Returns
600216 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -6.6% | -2.9% | -2.8% |
1Y | 40.5% | -10.1% | -18.4% |
Return vs Industry: 600216 exceeded the CN Pharmaceuticals industry which returned -10.1% over the past year.
Return vs Market: 600216 exceeded the CN Market which returned -18.4% over the past year.
Price Volatility
600216 volatility | |
---|---|
600216 Average Weekly Movement | 7.8% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 600216's share price has been volatile over the past 3 months.
Volatility Over Time: 600216's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 6,227 | Chun Lei Lu | www.zmc.top |
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceutical products in China. The company products include synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also offers fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products.
Zhejiang Medicine Co., Ltd. Fundamentals Summary
600216 fundamental statistics | |
---|---|
Market cap | CN¥14.02b |
Earnings (TTM) | CN¥472.71m |
Revenue (TTM) | CN¥8.26b |
29.5x
P/E Ratio1.7x
P/S RatioIs 600216 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600216 income statement (TTM) | |
---|---|
Revenue | CN¥8.26b |
Cost of Revenue | CN¥5.60b |
Gross Profit | CN¥2.67b |
Other Expenses | CN¥2.19b |
Earnings | CN¥472.71m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.50 |
Gross Margin | 32.26% |
Net Profit Margin | 5.72% |
Debt/Equity Ratio | 7.8% |
How did 600216 perform over the long term?
See historical performance and comparison